SCHEMBL24623626

SCHEMBL24623626

c1ccc2c(c1)sc1nncnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 4/20 0.49
CDK5 Q00535 1/20 0.49
CDK5R1 Q15078 1/20 0.49
GPR3 P46089 1/20 0.41
EGFR P00533 4/20 0.40
HTR2C P28335 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
PIK3CA P42336 1/20 0.38
KRAS P01116 1/20 0.33
CLK1 P49759 2/20 0.33
CDC7 O00311 1/20 0.33
DBF4 Q9UBU7 1/20 0.33
MIF P14174 1/20 0.32
GABRA1 P14867 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623614 0.85 LIMK1 (0.45) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL24623999 0.79 KDM4E (0.34) LIMK1CDK5CDK5R1CLK1ALDH1A1
SCHEMBL24624011 0.77 CYP2A6 (0.33)
SCHEMBL24624003 0.76 LIMK1 (0.50) LIMK1CDK5CDK5R1CLK1CDC7
SCHEMBL24623997 0.76 CLK1 (0.53) LIMK1EGFRPIK3CACLK1CDC7
SCHEMBL15374732 0.75 GPR3 (0.46) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL24624594 0.69 GPR3 (0.50) LIMK1CDK5CDK5R1GPR3MIF
SCHEMBL606019 0.68 LIMK1 (0.50) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL16919871 0.68 MAPT (0.41) LIMK1CDK5CDK5R1GPR3EGFR
SCHEMBL25334942 0.67 ALDH1A1 (0.39) LIMK1CDK5CDK5R1GPR3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF Wuhan Tianma Microelectronics Co., Ltd. Shanghai Branch (CN) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223794-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND APPLICATION THEREOF NR0B2, FPR3, NPR3 LIMK1 3355/4885CDK5 1715/4885CDK5R1 1622/4885
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 LIMK1 351/4885CDK5 3542/4885CDK5R1 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.